Brasofensine maleate(BMS-204756) sulfate is an oral active dopamine transporter antagonist and can be used for parkinson’s disease research[1].
References
[1] Frackiewicz, E. J, et al. Brasofensine Treatment for Parkinson’s Disease in Combination with Levodopa/Carbidopa. Annals of Pharmacotherapy, 36(2), 225–230. DOI:10.1345/aph.1A152